Free vs Total Testosterone: What the Difference Actually Means for Your Health

What Total Testosterone Actually Measures

Total testosterone is the sum of every testosterone molecule circulating in your blood, regardless of whether any of it can enter a cell and do anything. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism defines the lower limit of normal for total testosterone as 300 ng/dL in adult men, measured by a reliable assay such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) [1]. Most routine labs still use immunoassays, which carry a coefficient of variation of 10 to 15% at low concentrations, meaning a single reading of 295 ng/dL on an immunoassay may represent a "true" value anywhere from roughly 250 to 340 ng/dL.

Total testosterone is the standard first-line test because it is cheap, widely available, and sufficient for the majority of men whose SHBG is in a normal range. The problem is that SHBG is not in a normal range for a sizeable fraction of the men who seek evaluation. A 2019 analysis published in the Journal of Clinical Endocrinology and Metabolism found SHBG levels vary more than six-fold across a population of healthy adult men, which means two men with identical total testosterone values can have free testosterone levels that differ by a factor of three or more [2]. That variability is why total T alone frequently misleads clinicians.

Blood draws for testosterone should be done in the morning, ideally between 7 and 10 a.m., because diurnal variation can drop total testosterone by 20 to 35% between morning and afternoon in younger men [3]. A single low result should always be confirmed on a second morning draw before any treatment decision.

What Free Testosterone Is and Why It Matters More

Free testosterone is the unbound fraction, roughly 1 to 3% of total testosterone in men, that diffuses directly across cell membranes to bind androgen receptors. It is the biologically active pool that drives the effects most men associate with healthy testosterone levels: libido, lean muscle maintenance, erythropoiesis, mood stability, and bone mineral density preservation.

The 2018 Endocrine Society guideline states directly: "We suggest measuring free testosterone concentration in men in whom total testosterone is near the lower limit of normal (i.e., 300 to 400 ng/dL) because SHBG abnormalities may result in discordance between total and free testosterone" [1]. A man with total T at 380 ng/dL and an SHBG of 72 nmol/L could have calculated free T below 40 pg/mL, a level associated with symptomatic hypogonadism even though total T looks acceptable.

Free testosterone is not easy to measure directly. Equilibrium dialysis is the gold-standard method for direct measurement, but it is expensive and not widely available in routine clinical labs [4]. Most clinicians instead use calculated free testosterone, derived from total T, SHBG, and albumin using the Vermeulen equation. The Vermeulen formula has been validated against equilibrium dialysis and performs well when albumin is assumed at 4.3 g/dL [5]. HealthRX panels automatically calculate free T using this method whenever total T and SHBG are both drawn.

The practical threshold most TRT prescribers use is a calculated free T below 50 pg/mL in a symptomatic man, combined with corroborating signs such as a morning IIEF-5 score below 17 or ADAM questionnaire positivity on five or more items. That combination, rather than any single number, is what should trigger a treatment conversation.

SHBG Explained: The Protein That Controls How Much Testosterone Reaches Your Cells

Sex hormone-binding globulin is a glycoprotein produced mainly by the liver. It binds testosterone with high affinity, roughly 1,000 times stronger than albumin. Once testosterone is bound to SHBG, it cannot cross most cell membranes and cannot activate androgen receptors. Understanding what raises and lowers SHBG is essential for interpreting any testosterone panel.

Factors that raise SHBG:

Aging is the most clinically significant driver. A longitudinal analysis from the Massachusetts Male Aging Study showed SHBG increases approximately 1.2% per year after age 40, independent of changes in total testosterone [6]. Hyperthyroidism, liver disease with elevated synthetic function, and estrogen exposure (including aromatization from exogenous testosterone) also increase hepatic SHBG production. Caloric restriction and significant weight loss can raise SHBG by reducing insulin, which is itself a suppressor of SHBG gene expression.

Factors that lower SHBG:

Obesity and insulin resistance are the most common. Hyperinsulinemia suppresses SHBG at the transcriptional level, which is why obese men often have low SHBG and apparently normal or even high total testosterone alongside genuinely low free T. Hypothyroidism, glucocorticoid excess, and use of anabolic androgens all reduce SHBG as well.

A reference range for SHBG in adult men runs from approximately 10 to 57 nmol/L, though some labs use slightly different cutoffs. An SHBG above 60 nmol/L in a man with borderline total testosterone should prompt calculation of free T before any treatment decision is made.

Bioavailable Testosterone: The Third Number You Should Know

Bioavailable testosterone (bio-T) adds the albumin-bound fraction to free testosterone. Albumin binds testosterone loosely enough that the hormone can dissociate in the capillary bed and enter adjacent tissue. The albumin-bound pool represents 33 to 54% of total testosterone, and most researchers consider it biologically accessible [7].

Bio-T = free T + albumin-bound T

Normal bio-T in adult men ranges from approximately 130 to 450 ng/dL, depending on the lab and the age of the reference population. Some clinicians prefer bio-T over calculated free T because it captures a larger physiologically relevant pool. The Endocrine Society guideline notes that bioavailable testosterone may be more informative than total testosterone in older men and in men with obesity, since both conditions alter SHBG independently of androgen production [1].

In practice, bio-T and calculated free T typically tell the same clinical story. If they diverge, the most common explanation is an albumin measurement outside the assumed 4.3 g/dL used in most calculators. Patients with nephrotic syndrome, cirrhosis, or severe malnutrition will have genuinely low albumin, which reduces bio-T without affecting free T.

The HPG Axis: How the Brain Governs Testosterone Production

The hypothalamic-pituitary-gonadal (HPG) axis is the feedback loop that sets how much testosterone your testes produce. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses every 60 to 90 minutes. Those pulses drive the anterior pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH acts on Leydig cells in the testes, stimulating testosterone synthesis. Rising testosterone then feeds back to suppress both hypothalamic GnRH and pituitary LH, completing the loop.

Measuring LH alongside testosterone is diagnostically important. A man with total T of 250 ng/dL and LH of 12 IU/L has primary hypogonadism (the testes are failing despite maximal pituitary stimulation). A man with the same total T and LH of 1.2 IU/L has secondary hypogonadism (the pituitary or hypothalamus is not signaling adequately). Treatment pathways differ substantially: primary hypogonadism is managed with exogenous testosterone, whereas secondary hypogonadism may respond to clomiphene citrate, kisspeptin analogs, or pulsatile GnRH therapy depending on the underlying cause [8].

HPG axis suppression from exogenous testosterone is the single most important concept for any man starting TRT to understand. Within days of the first injection or application of exogenous testosterone, circulating T levels rise above the physiologic threshold. The hypothalamus detects this and reduces GnRH pulse amplitude. LH and FSH fall, often to undetectable levels within 4 to 8 weeks. Without LH stimulation, Leydig cell testosterone production ceases, and testicular size decreases by roughly 20 to 30% over 6 to 12 months of continuous therapy [9]. This suppression is reversible in most men after cessation of TRT, but recovery of the HPG axis may take 3 to 18 months depending on duration of use, age, and individual variability.

For men on TRT who want to preserve fertility or testicular volume, concurrent use of human chorionic gonadotropin (hCG) at 500, 1 to 000 IU two to three times per week can maintain intratesticular testosterone and Leydig cell function by acting as an LH analog [10]. The American Urological Association's 2018 guidelines on male infertility note that testosterone alone is not a contraceptive strategy men should rely on, but exogenous testosterone reliably suppresses spermatogenesis in most men after 3 to 4 months [8].

Aromatization: How Testosterone Becomes Estrogen and What That Means for Your Lab Values

Testosterone does not stay testosterone. The enzyme aromatase (CYP19A1) converts testosterone to estradiol (E2) irreversibly. In men, the majority of circulating estradiol comes from peripheral aromatization of testosterone, not from direct testicular secretion [11]. Adipose tissue is the primary site of aromatization, which is why men with higher body fat tend to have elevated E2 and, paradoxically, symptoms of both low testosterone and high estrogen simultaneously.

Normal estradiol in men ranges from approximately 10 to 40 pg/mL (36, 147 pmol/L). Estradiol is not merely a byproduct to suppress. It plays essential roles in male bone mineral density, cardiovascular health, and even libido [12]. A 2013 study by Finkelstein et al. published in the New England Journal of Medicine (N=198) demonstrated that sexual function and libido in men depended on estradiol as much as on testosterone, and that suppressing estradiol with an aromatase inhibitor (anastrozole) caused significant declines in libido and increased fat mass even when testosterone levels were maintained [12].

The clinical implication: aromatase inhibitors should not be used routinely in TRT to push estradiol down to "low" values. The Endocrine Society guideline explicitly states it "recommends against the routine use of aromatase inhibitors" in hypogonadal men [1]. Estradiol should be managed with dose adjustment of testosterone before an AI is considered, and an AI should only be added when a man has symptomatic high estradiol (gynecomastia, fluid retention, emotional lability) confirmed by LC-MS/MS assay, not immunoassay, at E2 levels consistently above 42, 45 pg/mL.

On TRT, aromatization increases because more substrate (testosterone) is available. Men with higher adiposity aromatize more aggressively. A man injecting testosterone cypionate 200 mg weekly will typically see a larger E2 rise than a man injecting 100 mg weekly, and an obese man will see a larger rise still. Free testosterone affects E2 indirectly: higher SHBG reduces the free T available for aromatization, so men with elevated SHBG on TRT may have less E2 elevation relative to their total testosterone dose.

How to Read Your Own Testosterone Lab Panel

A complete testosterone evaluation should include at minimum: total testosterone (LC-MS/MS preferred), SHBG, LH, FSH, estradiol (LC-MS/MS), complete blood count (hematocrit), and a morning draw time noted on the requisition. The calculated free T and bioavailable T can be generated from total T, SHBG, and an assumed albumin of 4.3 g/dL using the Vermeulen calculator at issam.ch or equivalent validated tools.

Reading the numbers in sequence:

1. Total testosterone below 300 ng/dL on two morning draws: consistent with hypogonadism.
2. Total T 300 to 400 ng/dL with symptoms: calculate free T. If free T <50 pg/mL, treat the free T, not the total.
3. Total T 300 to 400 ng/dL, SHBG above 50 nmol/L: free T likely low; calculate before deciding.
4. Total T above 400 ng/dL with symptoms: check SHBG. If SHBG is very high, free T may still be deficient.
5. LH and FSH low with low T: secondary hypogonadism. Imaging (pituitary MRI) and prolactin measurement are indicated.
6. LH and FSH high with low T: primary hypogonadism. Karyotype and testicular ultrasound should be considered.
7. Estradiol above 40 pg/mL: note whether immunoassay or LC-MS/MS was used. Immunoassay E2 results in men are unreliable; always confirm elevated values with LC-MS/MS before acting.

The Endocrine Society states: "We recommend measuring serum testosterone levels using an accurate and reliable assay... We recommend against using free testosterone assays based on analogue methods because these are inaccurate" [1]. Analogue (direct) free T assays sold by many commercial labs as a standard add-on are not validated and should not be used to make treatment decisions. Use only calculated free T (Vermeulen) or equilibrium dialysis.

What Normal Ranges Mean (and Don't Mean)

Reference ranges on lab reports are derived from population distributions, typically the 2.5th to 97.5th percentiles of healthy young adult men. A "normal" range of 300, 1 to 000 ng/dL for total testosterone does not mean a 58-year-old man with fatigue, erectile dysfunction, and a total T of 305 ng/dL should be told his levels are "fine." Reference ranges do not account for age-stratified norms, individual baseline variation, SHBG status, or symptomatic context.

A 2017 analysis in JAMA Internal Medicine (N=9,054 men from NHANES) found that total testosterone levels in US men have declined roughly 1% per year since the 1980s, with men born in 1970 having testosterone levels approximately 17% lower at any given age than men born in 1940 [13]. Population norms are themselves shifting, which means a lab report calling 310 ng/dL "normal" based on a reference population that may already be partially hypogonadal is not clinically reassuring.

The target on TRT is not "above the lower limit of normal." For most men on TRT, mid-normal to upper-normal total testosterone (550 to 900 ng/dL) with free T in the 100, 200 pg/mL range represents an appropriate physiologic replacement target, balancing symptom relief against the risk of polycythemia (hematocrit above 54%), which is the most common dose-dependent adverse effect of TRT [1].